Skip to main content
Log in

Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Several drugs with a catechol moiety were studied for their potency to inhibit tyrosine hydroxylase (TH) from PC-12 cells in vitro. When the natural compounds tested were compared, dopamine, norepinephrine and 2(3,4-dihydroxyphenyl)-ethanol (DOPET) were most effective (IC50 between 1.4 and 3.6 μM with 0.5 μM 6(R,S)-l-erythro-5,6,7,8-tetrahydrobiopterin as cofactor). 3,4-Dihydroxyphenylalanine (DOPA; IC50: 35 μM) and 3,4-dihydroxyphenylacetic acid (DOPAC; IC50: 180 μM were less potent inhibitors. Among the synthetic drugs possessing catechol moiety, isoproterenol, (±)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN) and (±)-2-dimethylamino-6,7-dihydroxy-tetrahydronaphthalene (TL-99) had the same inhibitory effects as the natural catecholamines (IC50 between 1.6 and 3.9 μM), whereas the apomorphine derivatives and 2,3,4,5-tetrahydro-1-phenyl-1 H-3-benzazepine-7,8-diol (SKF 38393) were even more potent (IC50: 0.5–0.8 μM).

These results demonstrate that natural catechols and certain drugs (e.g. 6,7-ADTN, TL-99, SKF 38393) are more effective direct blockers of tyrosine hydroxylase than generally assumed provided appropriate assay conditions are used. In the case of dopamine and norepinephrine, these findings suggest a reevaluation of their role for feedback control of tyrosine hydroxylase in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

6,7-ADTN:

(±)-2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene

BH4 :

6(R,S)-l-erythro-5,6,7,8-tetrahydrobiopterin

DMPH4 :

2-amino-4-hydroxy-6,7-dimethyl-tetrahydropteridine

DOPA:

3,4-dihydroxyphenylalanine

DOPAC:

3,4-dihydroxyphenylacetic acid

DOPET:

2(3,4-dihydroxyphenyl)ethanol

ELCD:

electrochemical detection

6-MPH4 :

6-methyl-5,6,7,8-tetrahydropteridine

NSD 1015:

3-hydroxy-benzyl-hydrazine

SKF 38393:

2,3,4,5-tetrahydro-1-phenyl-1 H-3-benzazepine-7,8-diol

TH:

tyrosine hydroxylase

TL-99:

(±)-2-dimethylamino-6,7-dihydroxy-tetrahydronaphthalene

References

  • Acheson AL, Kapatos G, Zigmond MJ (1981) The effects of phosphorylating conditions on tyrosine hydroxylase activity are influenced by assay conditions and brain region. Life Sci 28:1407–1420

    Google Scholar 

  • Ames MM, Lerner P, Lovenberg W (1978) Tyrosine hydroxylase: Activation by protein phosphorylation and end product inhibition. J Biol Chem 253:27–31

    Google Scholar 

  • Bräutigam M, Dreesen R, Herken H (1982) DOPA-release from mouse neuroblastoma clone N1E-115 into the culture medium — a test for tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Arch Pharmacol 320:85–89

    Google Scholar 

  • Bräutigam M, Dreesen R, Herken H (1984) Tetrahydrobiopterin and total biopterin content of neuroblastoma (N1E-115, N2A) and pheochromocytoma (PC-12) clones and the dependence of catecholamine synthesis on tetrahydrobiopterin concentration in PC-12 cells. J Neurochem 42:390–396

    Google Scholar 

  • Bräutigam M, Kittner B, Laschinski G, Herken H (1985) Effect of apomorphine, d-methylparatyrosine, haloperidol and reserpine on DOPA production in clonal cells lines (PC-12 and N1E-115). Biochem Pharmacol 34:941–947

    Google Scholar 

  • Bullard WP, Guthrie PB, Russo PV, Mandell AJ (1978) Regional and subcellular distribution and some factors in the regulation of reduced pterins in rat brain. J Pharmacol Exp Ther 206: 4–20

    Google Scholar 

  • Carlsson A, Kehr W, Lindqvist M (1976) The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. J Neural Transm 39:1–19

    Google Scholar 

  • Fisher DB, Kaufman S (1972) The inhibition of phenylalanine and tyrosine hydroxylases by high oxygen levels. J Neurochem 19:1359–1365

    Google Scholar 

  • Foreman MM, Porter, JC (1980) Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity. J Neurochem 34:1175–1183

    Google Scholar 

  • Fowler CJ, Thorell G, Andersson M, Magnusson O (1985) Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function? Naunyn-Schmiedeberg's Arch Pharmacol 331:12–19

    Google Scholar 

  • Gál EM, Sherman AD (1976) Biopterin II. Evidence for cerebral synthesis of 7,8-dihydrobiopterin in vivo and in vitro. Neurochem Res 1:627–639

    Google Scholar 

  • Goodale DB, Rusterholz DB, Long JP, Flynn JR, Walsh B, Cannon JG, Lee T (1980) Neurochemical and behavioural evidence for a selective presynaptic dopamine receptor agonist. Science 210:1141–1143

    Google Scholar 

  • Hegstrand LR, Simon JR, Roth RH (1979) Tyrosine hydroxylase: Examination of conditions influencing activity in pheochromocytoma, adrenal medulla and striatum. Biochem Pharmacol 28:519–523

    Google Scholar 

  • Ikeda M, Fahien LA, Udenfriend S (1966) A kinetic study of bovine adrenal hydroxylase. J Biol Chem 241:4452–4456

    Google Scholar 

  • Kapatos G, Zignond MJ (1982) Influence of calcium on dopamine synthesis and tyrosine hydroxylase activity in rat striatum. J Neurochem. 39:327–335

    Google Scholar 

  • Kato T, Oka K, Nagatsu T, Sugimoto T, Matsuura S (1980) Effects of structures of tetrahydrobiopterin cofactors on tyrosine hydroxylase. Biochim Biophys Acta 612:226–232

    Google Scholar 

  • Kuczenski R (1973) Soluble, membrane-bound, and detergent-solubilized rat striatal tyrosine hydroxylase. J Biol Chem 248:5074–5080

    Google Scholar 

  • Kuczenski R (1981) Monovalent cations and striatal tyrosine hydroxylase. J Neurochem 37:681–686

    Google Scholar 

  • Laschinski G, Kittner B, Bräutigam M (1984) Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine. Naunyn-Schmiedeberg's Arch Pharmacol 327:114–118

    Google Scholar 

  • Lazar MA, Barchas JD (1982) The regulation of tyrosine hydroxylase activity by phosphorylation. Adv Biosci 37:285–290

    Google Scholar 

  • Levine RA, Miller LP, Lovenberg W (1981) Tetrahydrobiopterin in striatum: Localization in dopamine nerve terminals and role in catecholamine synthesis. Science 214:919–920

    Google Scholar 

  • Levitt M, Spector S, Sjoerdsma A, Udenfriend S (1965) Elucidation of the rate-limiting step in norepinephrine biosynthesis in the perfused guinea-pig heart. J Pharmacol Exp Ther 148:1–8

    Google Scholar 

  • Levitt M, Gibb JW, Daly JW, Lipton M, Udenfriend S (1967) A new class of tyrosine hydroxylase inhibitors and a simple assay of inhibition in vivo. Biochem Pharmacol 16:1313–1321

    Google Scholar 

  • Lloyd, T, Ebersole BJ (1980) Feedback inhibition of tyrosine hydroxylase from five regions of rat brain by 2-hydroxyestradiol and dihydroxyphenylalanine. J Neurochem 31:726–731

    Google Scholar 

  • Lowry OH, Rosebrough HJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Markey KA, Kondo S, Shenkman L, Goldstein M (1980) Purification and characterization of tyrosine hydroxylase from a clonal pheochromocytoma cell line. Mol Pharmacol 17:79–83

    Google Scholar 

  • Martin GE, Haubrich DR, Williams M (1981) Pharmacological profiles of the putative dopamine autoreceptor agonist 3-PPP and TL-99. Eur J Pharmacol 76:15–23

    Google Scholar 

  • Nagatsu T, Levitt M, Udenfriend S (1964) Tyrosine hydroxylase: The initial step in norepinephrine biosynthesis. J Biol Chem 239:2910–2917

    Google Scholar 

  • Nagatsu T, Oka K, Kato T (1979) High sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J Chromat 163:247–252

    Google Scholar 

  • Oka K, Kato T, Sugimoto T, Matsuura S, Nagatsu T (1981) Kinetic properties of tyrosine hydroxylase with natural tetrahydrobiopterin as cofactor. Biochim Biophys Acta 661:45–53

    Google Scholar 

  • Perlman RL, Sheard EB (1982) Estimation of the cytoplasmic catecholamine concentrations in pheochromocytoma cells. Biochim Biophys Acta 719:334–340

    Google Scholar 

  • Petrack B, Sheppy F, Fetzer V (1968) Studies on tyrosine hydroxylase from bovine adrenal medulla. J Biol Chem 243:743–748

    Google Scholar 

  • Pollock RJ, Kapatos G, Kaufman S (1981) Effect of cyclic AMP-dependent protein phosphorylation conditions on the pH-dependent activity of tyrosine hydroxylase from beef and rat strita. J Neurochem 37:855–860

    Google Scholar 

  • Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32:229–313

    Google Scholar 

  • Shen R, Smith RV, Davis PJ, Creed WA (1984) Inhibition of dihydropteridine reductase from human liver and rat striatal synaptosomes by apomorphine and its analogues. J Biol Chem 259:8994–9000

    Google Scholar 

  • Simon JR, Hegstrand LR, Roth RH (1978) Regulation of tyrosine hydroxylase from human pheochromocytoma, bovine adrenal and rat striatum. Life Sci 22:421–428

    Google Scholar 

  • Udenfriend S, Zaltzman-Nirenberg P, Nagatsu T (1965) Inhibitors of purified beef adrenal tyrosine hydroxylase. Biochem Pharmacol 14:837–845

    Google Scholar 

  • Waggoner WG, McDermed J, Leighton HJ (1980) Presynaptic regulation of tyrosine hydroxylase activity in rat striatal synaptosomes by dopamine analogs. Mol Pharmacol 18:91–99

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Laschinski, G., Kittner, B. & Bräutigam, M. Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 346–350 (1986). https://doi.org/10.1007/BF00500085

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500085

Key words

Navigation